Waltham, Massachusetts, July 7, 2026 /PRNewswire/ — Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, today announced that it has been awarded the Platinum Pinnacle Award for Technology in the Best Use of Artificial Intelligence category. This recognition recognizes Trinity’s groundbreaking InsightsEDGE™ | The Digital Twins platform is an AI-powered solution that transforms the way life sciences organizations generate commercial insights, predict market trends, and make strategic decisions.
The Platinum honor recognizes organizations that have demonstrated outstanding innovation and measurable business impact through artificial intelligence. Trinity won the top award in this category for its digital twin platform that creates continuously learning virtual replicas of healthcare professionals (HCPs), patients, and payers. This enables commercial teams to test scenarios, simulate conversations, and access always-on intelligence based on real-world data.
“Winning the Platinum Pinnacle Award is a tremendous honor and validates our vision of how artificial intelligence can fundamentally change the commercialization of life sciences,” said Trinity CEO Scott Evangelista. “Rather than replacing human expertise, InsightsEDGE | Digital Twins amplifies it by combining Trinity’s decades of commercial and scientific knowledge with advanced AI to deliver faster, more informed decisions. We believe this represents the future of commercial intelligence in the industry.”
Released earlier this year, InsightsEDGE | Digital Twins extends Trinity’s AI-powered InsightsEDGE platform by transforming traditional static market research into continuously evolving customer intelligence. Powered by Trinity Weave, the company’s proprietary AI-enabled unified data fabric, the platform integrates primary market research, prescription claims, CRM data, field insights, and other commercial datasets to create a dynamic, data-driven digital representation of key healthcare stakeholders.
“Artificial intelligence delivers the most value when it is based on trusted data, deep domain expertise, and rigorous scientific testing,” said Jonathan Jenkins, Head of AI & Digital Solutions at Trinity. “Digital twins are a new generation of AI purpose-built for life sciences, helping commercial teams go beyond static reports and gain insights faster, more reliably, and at a lower cost. This continuously learning intelligence becomes more valuable with each interaction.”
The Pinnacle Award further highlights Trinity’s extensive commitment to helping life sciences organizations responsibly leverage artificial intelligence to improve commercialization strategies, accelerate the generation of insights, and ultimately support better patient outcomes.
About Trinity
Trinity is driving the future of life sciences commercialization through the convergence of humans and artificial intelligence. By combining deep therapeutic expertise and trusted human ingenuity with a purpose-built technology platform, Trinity accelerates clarity and confidence at every stage of commercialization, from pre-launch to scale-up to loss of exclusivity. For more than 30 years, the world’s leading pharmaceutical, biotechnology, and medical technology companies have relied on Trinity’s vision, execution, and partnerships to deliver confident product launches, decisive market advantages, and measurable patient impact. During that time, Trinity has expanded from its first office in Waltham, Massachusetts to 14 offices and 1,300 professionals across five continents, setting new industry standards in quality, responsiveness and client partnership. For more information, please visit Trinity at www.trinitylifesciences.com.
source trinity
